Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2

…, F Fagnoni, L Ponchio, M Scelsi, E Tagliabue… - Clinical cancer …, 2004 - AACR
Purpose: To elucidate the mechanism by which trastuzumab, a humanized monoclonal
antibody against HER2 with proven survival benefit in women with HER2-positive metastatic …

Biologic and therapeutic role of HER2 in cancer

S Menard, SM Pupa, M Campiglio, E Tagliabue - Oncogene, 2003 - nature.com
Overexpression of the human epidermal growth factor-2 (HER2) oncogene in human breast
carcinomas has been associated with a more aggressive course of disease. The reason for …

Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy

…, P Filipazzi, L Rivoltini, E Tagliabue… - Journal of cellular …, 2012 - Wiley Online Library
Exosomes are endosome‐derived nanovesicles actively released into the extracellular
environment and biological fluids, both under physiological and pathological conditions, by …

[HTML][HTML] Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

…, L Lugini, T Triulzi, A Tuccitto, E Tagliabue… - Seminars in cancer …, 2017 - Elsevier
The link between cancer metabolism and immunosuppression, inflammation and immune
escape has generated major interest in investigating the effects of low pH on tumor immunity. …

Role of HER2 gene overexpression in breast carcinoma

S Menard, E Tagliabue, M Campiglio… - Journal of cellular …, 2000 - Wiley Online Library
The HER2 proto‐oncogene encodes a transmembrane glycoprotein of 185 kDa (p185 HER2
) with intrinsic tyrosine kinase activity. Amplification of the HER2 gene and overexpression …

microRNA-205 regulates HER3 in human breast cancer

…, A Merlo, T Triulzi, S Ménard, CM Croce, E Tagliabue - Cancer research, 2009 - AACR
An increasing amount of experimental evidence shows that microRNAs can have a causal
role in breast cancer tumorigenesis as a novel class of oncogenes or tumor suppressor genes…

New insights into the role of extracellular matrix during tumor onset and progression

…, S Ménard, S Forti, E Tagliabue - Journal of cellular …, 2002 - Wiley Online Library
Recently, a view of the tumor as a functional tissue interconnected with the microenvironment
has recently been described. For many years, the stroma has been studied in the context …

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.

F Pezzella, U Pastorino, E Tagliabue… - The American journal …, 1997 - ncbi.nlm.nih.gov
Neoplastic growth is usually dependent on blood supply, and it is commonly accepted that
this is provided by the formation of new vessels. However, tumors may be able to grow …

[HTML][HTML] Triple-negative breast cancer: present challenges and new perspectives

…, H Wouters, HG Russnes, T Sørlie, E Tagliabue… - Molecular …, 2010 - Elsevier
Triple-negative breast cancers (TNBC), characterized by absence of estrogen receptor (ER),
progesterone receptor (PR) and lack of overexpression of human epidermal growth factor …

Replacement of Fhit in cancer cells suppresses tumorigenicity

…, V Eryomin, L Sard, E Tagliabue… - Proceedings of the …, 1997 - National Acad Sciences
The candidate tumor suppressor gene, FHIT, encompasses the common human chromosomal
fragile site at 3p14.2, the hereditary renal cancer translocation breakpoint, and cancer cell …